BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37272295)

  • 21. Overexpression of hexokinase-2 in giant cell tumor of bone is associated with false positive in bone tumor on FDG-PET/CT.
    Hoshi M; Takada J; Oebisu N; Hata K; Ieguchi M; Nakamura H
    Arch Orthop Trauma Surg; 2012 Nov; 132(11):1561-8. PubMed ID: 22825642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of focal hypermetabolic thyroid incidentaloma: An analysis with F-18 fluorodeoxyglucose positron emission tomography/computed tomography parameters.
    Lee H; Chung YS; Lee JH; Lee KY; Hwang KH
    World J Clin Cases; 2022 Jan; 10(1):155-165. PubMed ID: 35071515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dual-time point PET/CT with F-18 FDG for the differentiation of malignant and benign bone lesions.
    Tian R; Su M; Tian Y; Li F; Li L; Kuang A; Zeng J
    Skeletal Radiol; 2009 May; 38(5):451-8. PubMed ID: 19205695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence and significance of thyroid uptake detected by ¹⁸F-FDG PET.
    Ho TY; Liou MJ; Lin KJ; Yen TC
    Endocrine; 2011 Oct; 40(2):297-302. PubMed ID: 21505891
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The additional value of CT images interpretation in the differential diagnosis of benign vs. malignant primary bone lesions with 18F-FDG-PET/CT.
    Strobel K; Exner UE; Stumpe KD; Hany TF; Bode B; Mende K; Veit-Haibach P; von Schulthess GK; Hodler J
    Eur J Nucl Med Mol Imaging; 2008 Nov; 35(11):2000-8. PubMed ID: 18712385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thyroid incidentaloma identified by ¹⁸F-fluorodeoxyglucose positron emission tomography with CT (FDG-PET/CT): clinical and pathological relevance.
    Pagano L; Samà MT; Morani F; Prodam F; Rudoni M; Boldorini R; Valente G; Marzullo P; Baldelli R; Appetecchia M; Isidoro C; Aimaretti G
    Clin Endocrinol (Oxf); 2011 Oct; 75(4):528-34. PubMed ID: 21575027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Focal thyroid lesions incidentally identified by integrated 18F-FDG PET/CT: clinical significance and improved characterization.
    Choi JY; Lee KS; Kim HJ; Shim YM; Kwon OJ; Park K; Baek CH; Chung JH; Lee KH; Kim BT
    J Nucl Med; 2006 Apr; 47(4):609-15. PubMed ID: 16595494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Isolated Malignant Portal Vein Thrombus in Colon Carcinoma: A Rare Finding on
    Jain TK; Yadav A; Malhotra H; Khunteta N; Singh G
    J Nucl Med Technol; 2021 Jun; 49(2):190-192. PubMed ID: 33219156
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic value of
    Zhu AH; Hou XY; Tian S; Zhang WF
    Sci Rep; 2022 Jan; 12(1):587. PubMed ID: 35022440
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The incidence of thyroid cancer in focal hypermetabolic thyroid lesions: an 18F-FDG PET/CT study in more than 6000 patients.
    Barrio M; Czernin J; Yeh MW; Palma Diaz MF; Gupta P; Allen-Auerbach M; Schiepers C; Herrmann K
    Nucl Med Commun; 2016 Dec; 37(12):1290-1296. PubMed ID: 27612034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of ¹⁸F-FDG PET/CT in differentiation of a benign lesion and metastasis on the ribs of cancer patients.
    Choi HS; Yoo IeR; Park HL; Choi EK; Kim SH; Lee WH
    Clin Imaging; 2014; 38(2):109-14. PubMed ID: 24361174
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differentiation between malignant and benign pathologic fractures with F-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography.
    Shin DS; Shon OJ; Byun SJ; Choi JH; Chun KA; Cho IH
    Skeletal Radiol; 2008 May; 37(5):415-21. PubMed ID: 18309481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. F-18 FDG PET/CT in the management of thyroid cancer.
    Iagaru A; Kalinyak JE; McDougall IR
    Clin Nucl Med; 2007 Sep; 32(9):690-5. PubMed ID: 17710020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
    Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
    Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
    [TBL] [Abstract][Full Text] [Related]  

  • 35. FDG PET-CT in cervical cancer: relationship between primary tumor FDG uptake and metastatic potential.
    Yilmaz M; Adli M; Celen Z; Zincirkeser S; Dirier A
    Nucl Med Commun; 2010 Jun; 31(6):526-31. PubMed ID: 20215979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Positron emission tomography/computed tomography with (18)F-fluorodeoxyglucose identifies tumor growth or thrombosis in the portal vein with hepatocellular carcinoma.
    Sun L; Wu H; Pan WM; Guan YS
    World J Gastroenterol; 2007 Sep; 13(33):4529-32. PubMed ID: 17724816
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Additional value of FDG PET/CT to contrast-enhanced CT in the differentiation between benign and malignant intraductal papillary mucinous neoplasms of the pancreas with mural nodules.
    Takanami K; Hiraide T; Tsuda M; Nakamura Y; Kaneta T; Takase K; Fukuda H; Takahashi S
    Ann Nucl Med; 2011 Aug; 25(7):501-10. PubMed ID: 21537945
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperaccumulation of (18)F-FDG in order to differentiate solid pseudopapillary tumors from adenocarcinomas and from neuroendocrine pancreatic tumors and review of the literature.
    Guan ZW; Xu BX; Wang RM; Sun L; Tian JH
    Hell J Nucl Med; 2013; 16(2):97-102. PubMed ID: 23687644
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of incidental focal hypermetabolic uptake in the breast as detected by 18F-FDG PET/CT: clinical significance and differential diagnosis.
    Chae EY; Cha JH; Kim HH; Shin HJ; Kim HJ; Oh HY; Koh YH; Moon DH
    Acta Radiol; 2012 Jun; 53(5):530-5. PubMed ID: 22593124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bilateral hilar foci on 18F-FDG PET scan in patients without lung cancer: variables associated with benign and malignant etiology.
    Karam M; Roberts-Klein S; Shet N; Chang J; Feustel P
    J Nucl Med; 2008 Sep; 49(9):1429-36. PubMed ID: 18765585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.